Advanced Life Sciences Inc. Earnings Conference Call (Q1 2008)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other May 7 Calls Today's Calls

Call Details Advanced Life Sciences Inc. Earnings Conference Call (Q1 2008) Wed, May 7, 2008, 10:00 am Eastern Listen to the archived event audio About Advanced Life Sciences Inc. (NasdaqCM:ADLS) Other Calls  Advanced Life Sciences Holdings, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs in the areas of infectious disease, oncology, and inflammation. The company has a worldwide license from Abbott Laboratories to develop and commercialize its lead candidate, cethromycin, an antibiotic that is in Phase III clinical development for the treatment of respiratory tract infections. It is also developing ALS-357, a compound for the treatment of malignant melanoma; and ALS-886, a therapeutic that is in preclinical development for the treatment of inflammation-related tissue damage, including tissue damage associated with acute respiratory distress syndrome. In addition, the company has additional product candidates in preclinical development coming from its natural products-based chemistry platform. Advanced Life Sciences Holdings has collaborations and license agreements with University of Illinois at Chicago, Baxter International, Argonne National Laboratory, and the National Institute of Allergy and Infectious Diseases. The company was founded in 1999 and is headquartered in Woodridge, Illinois. More Info: Quote | Profile | Reports | Research | Msgs | Insider | Financials | Analyst Ratings